Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

C4 Therapeutics (CCCC) Shares Issued (2019 - 2025)

C4 Therapeutics' Shares Issued history spans 7 years, with the latest figure at $107000.0 for Q3 2025.

  • For Q3 2025, Shares Issued rose 723.08% year-over-year to $107000.0; the TTM value through Sep 2025 reached $82.4 million, up 12254.87%, while the annual FY2025 figure was $107000.0, 86.25% down from the prior year.
  • Shares Issued reached $107000.0 in Q3 2025 per CCCC's latest filing, down from $82.3 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $82.3 million in Q4 2024 to a low of -$730000.0 in Q4 2022.
  • Average Shares Issued over 5 years is $5.7 million, with a median of $211000.0 recorded in 2022.
  • Peak YoY movement for Shares Issued: crashed 197.07% in 2022, then surged 6650.0% in 2024.
  • A 5-year view of Shares Issued shows it stood at $752000.0 in 2021, then plummeted by 197.07% to -$730000.0 in 2022, then surged by 100.27% to $2000.0 in 2023, then surged by 4114900.0% to $82.3 million in 2024, then tumbled by 99.87% to $107000.0 in 2025.
  • Per Business Quant, the three most recent readings for CCCC's Shares Issued are $107000.0 (Q3 2025), $82.3 million (Q4 2024), and $13000.0 (Q3 2024).